China · Delayed Price · Currency is CNY Shandong Keyuan Pharmaceutical Company Description
Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations.
It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride.
The company was founded in 2004 and is headquartered in Jinan, China.
| Country | China |
| Founded | 2004 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 696 |
| CEO | Chun Po Gao |
Contact Details
Address: Keyuan Street Jinan, 251601 China | |
| Phone | 86 531 8872 9285 |
| Website | keyuanpharm.com |
Stock Details
| Ticker Symbol | 301281 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000061V8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chun Po Gao | GM and Chairman |
| Chun Hua Li | Deputy GM, Chief Financial Officer, Accounting Supervisor and Secretary of the Board |